Medicare Part B Shift To Discourage Prescribing Of Costly New 340 Drugs Weighed By MedPAC

Recommendation Could Lower Medicare Spending On Oncology, Immunology Drugs
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Medicare

More from Government Payers